Tayahop, Renita T.
HRN: 22-50-21 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2023
CEFTRIAXONE 1G (VIAL)
01/21/2023
01/27/2023
IV
2g
Q 24H
Lacerated Wound, Occipital Area
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes